Hydrogenology
Hydrogenology editorial study record

Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gas.

McCurry MD, D'Agostino GD, Walsh JT, Bisanz JE, Zalosnik I, Dong X, Morris DJ, Korzenik JR, Edlow AG, Balskus EP, Turnbaugh PJ, Huh JR, Devlin AS. · Cell. 2024;187:2717-2732.

PreclinicalOther formsPublished 2024
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Mechanistic microbial, ex-vivo and animal study

Research topic

Gastrointestinal health

Administration classification

Other forms

Study result signal

Positive mechanistic signal; no therapeutic inference.

Outcome type

Mechanistic microbial and metabolic outcomes; not a therapeutic clinical outcome.

Reported in the source

Methods at a glance

Population or model

Gut bacterial cultures, human fecal-community experiments and mouse models.

Sample

Multiple culture, ex-vivo and animal experiments; sample sizes were reported by experiment.

Duration

Experiment-specific microbial, ex-vivo and animal schedules.

Intervention

Hydrogen-gas atmosphere or hydrogen-producing microbial conditions used to test steroid conversion.

Hydrogen form

Molecular H2 used as a microbial metabolic substrate; not a therapeutic inhalation intervention and not Brown's gas.

H₂ specification

Experimental H2 exposure varied by microbial assay; it was not administered as a patient treatment.

H₂ flow

Not applicable — anaerobic microbial culture/ex-vivo exposure.

O₂ delivered with H₂

No therapeutic oxygen co-delivery.

Comparator

Nitrogen or hydrogen-limited culture conditions and model-specific controls.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Microbial conversion of glucocorticoids to progestins, metabolites, gene/pathway activity and host-associated measures.

Reported result

Hydrogen availability enabled selected gut bacteria to convert glucocorticoids into progestins in the reported experimental systems.

Results-extraction completeness

The full article, microbial mechanism, controls and animal and ex-vivo experiments were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

This is mechanistic microbiome research, not evidence that administered hydrogen treats a disease.

Applies directly to

The reported bacterial, fecal-community and mouse experimental systems.

Preliminary appraisal framework

SYRCLE animal-study tool — preliminary

Preliminary risk-of-bias status

Some concerns

Appraisal rationale

Complex multi-model mechanistic study; animal allocation and blinding are not the primary basis of the microbial result.

Appraisal domains

Randomization/allocation reporting is limited · Blinding of personnel is unclear · Attrition is incompletely reported in places · Blinding of outcome assessors is unclear · No prospectively registered analysis plan identified

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 38795705 · DOI: 10.1016/j.cell.2024.05.005

Publisher access

Free full article in PubMed Central.

Extraction basis

PubMed record and PubMed Central full text; extraction checked 9 August 2026.

Record revision

2026-08-10